B. Hulka

发表

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

Julian Peto, Moyses Szklo, Anthony B. Miller, 1997, The Lancet.

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

V. Beral, R. Collins, M. Pike, 1997, The Lancet.

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

V. Beral, Jane Green, R. Collins, 2019, The Lancet.

Oral contraceptives and breast cancer: A case‐control study with hospital and community controls

B. Hulka, J. Schildkraut, Wells G Wilkinson, 1990, Obstetrics and gynecology.

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

Julian Peto, Moyses Szklo, Anthony B. Miller, 1996, The Lancet.

Hormones and breast and endometrial cancers: preventive strategies and future research.

L. Brinton, B. Hulka, 1995, Environmental health perspectives.

Hormone‐replacement therapy and the risk of breast cancer

B. Hulka, 1990, CA: a cancer journal for clinicians.

Breast cancer: cause and prevention

B. Hulka, A. Stark, B. Hulka, 1995, The Lancet.

Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

M. C. Leske, V. Beral, R. Collins, 2002, British Journal of Cancer.

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Heather Eliassen, Karen Canfell, Julian Peto, 2012, The Lancet. Oncology.